Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 2109-2119, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (63)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cole, L. A.
Right arrow Articles by Mahoney, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cole, L. A.
Right arrow Articles by Mahoney, M. J.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1999;45:2109-2119.)
© 1999 American Association for Clinical Chemistry, Inc.

Articles

Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen) Immunoassay: A New Basis for Gestational Down Syndrome Screening

Laurence A. Cole1,a, Shohreh Shahabi1, Utku A. Oz1, Ray O. Bahado-Singh1 and Maurice J. Mahoney1,2

Departments of
1 Obstetrics and Gynecology and
2 Genetics, Yale University School of Medicine, New Haven, CT 06510.
a Address correspondence to this author at: Center for Women’s Health Research, Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, 2211 Lomas Blvd., N.W., Albuquerque, NM 87131. Fax 505-272-6385; e-mail larry{at}hCGlab.com

Background: Serum human chorionic gonadotropin (hCG) and hCG free ß-subunit tests are used in combination with unconjugated estriol and {alpha}-fetoprotein in the triple screen test, and with the addition of inhibin-A in the quadruple marker test for detecting Down syndrome in the second trimester of pregnancy. These tests have a limited detection rate for Down syndrome: ~40% for hCG or free ß-subunit alone, ~60% for the triple screen test, and ~70% for the quadruple marker test, all at 5%, or a relatively high, false-positive rate. New tests are needed with higher detection and lower false rates. Hyperglycosylated hCG (also known as invasive trophoblast antigen or ITA) is a new test. It specifically detects a unique oligosaccharide variant of hCG associated with Down syndrome pregnancies. We evaluated this new Down syndrome-directed test in prenatal diagnosis.

Methods: Hyperglycosylated hCG was measured in urine samples from women undergoing amniocentesis for advanced maternal age concerns at 14–22 weeks of gestation, 1448 with normal karyotype and 39 with Down syndrome fetuses.

Results: The median hyperglycosylated hCG value was 9.5-fold higher in Down syndrome cases (9.5 multiples of the normal karyotype median). The single test detected 80% of Down syndrome cases at a 5% false-positive rate. Urine hyperglycosylated hCG was combined with urine ß-core fragment (urine breakdown product of serum hCG free ß-subunit), serum {alpha}-fetoprotein, and maternal age-related risk. This urine-serum combination detected 96% of Down syndrome cases at a 5% false-positive rate, 94% of cases at a 3% false-positive rate, and 71% of cases at a 1% false-positive rate. These detection rates exceed those of any previously reported combination of biochemical markers.

Conclusions: Hyperglycosylated hCG is a new base marker for Down syndrome screening in the second trimester of pregnancy. The measurement of hyperglycosylated hCG can fundamentally improve the performance of Down syndrome screening protocols.




The following articles in journals at HighWire Press have cited this article:


Home page
 GlycobiologyHome page
L. Valmu, H. Alfthan, K. Hotakainen, S. Birken, and U.-H. Stenman
Site-specific glycan analysis of human chorionic gonadotropin {beta}-subunit from malignancies and pregnancy by liquid chromatography--electrospray mass spectrometry
Glycobiology, December 1, 2006; 16(12): 1207 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. E. Palomaki, G. J. Knight, L. M. Neveux, R. Pandian, and J. E. Haddow
Maternal Serum Invasive Trophoblast Antigen and First-Trimester Down Syndrome Screening
Clin. Chem., August 1, 2005; 51(8): 1499 - 1504.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. J.N. Weinans, U. Sancken, R. Pandian, J. M.W. van de Ouweland, H. W.A. de Bruijn, J. P. Holm, and A. Mantingh
Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) as a First-Trimester Serum Marker for Down Syndrome
Clin. Chem., July 1, 2005; 51(7): 1276 - 1279.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. E. Palomaki, L. M. Neveux, G. J. Knight, J. E. Haddow, and R. Pandian
Maternal Serum Invasive Trophoblast Antigen (Hyperglycosylated hCG) as a Screening Marker for Down Syndrome during the Second Trimester
Clin. Chem., October 1, 2004; 50(10): 1804 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Pandian, L. A. Cole, and G. E. Palomaki
Second-Trimester Maternal Serum Invasive Trophoblast Antigen: A Marker for Down Syndrome Screening
Clin. Chem., August 1, 2004; 50(8): 1433 - 1435.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J.-L. Frendo, J. Guibourdenche, G. Pidoux, M. Vidaud, D. Luton, Y. Giovangrandi, D. Porquet, F. Muller, and D. Evain-Brion
Trophoblast Production of a Weakly Bioactive Human Chorionic Gonadotropin in Trisomy 21-Affected Pregnancy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 727 - 732.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. E. Palomaki, G. J. Knight, M. M. Roberson, G. C. Cunningham, J. E. Lee, C. M. Strom, and R. Pandian
Invasive Trophoblast Antigen (Hyperglycosylated Human Chorionic Gonadotropin) in Second-Trimester Maternal Urine as a Marker for Down Syndrome: Preliminary Results of an Observational Study on Fresh Samples
Clin. Chem., January 1, 2004; 50(1): 182 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. Pandian, J. Lu, and J. Ossolinska-Plewnia
Fully Automated Chemiluminometric Assay for Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen)
Clin. Chem., May 1, 2003; 49(5): 808 - 810.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Birken, P. Berger, J.-M. Bidart, M. Weber, A. Bristow, R. Norman, C. Sturgeon, and U.-H. Stenman
Preparation and Characterization of New WHO Reference Reagents for Human Chorionic Gonadotropin and Metabolites
Clin. Chem., January 1, 2003; 49(1): 144 - 154.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. C.W. Poon, T. S.K. Mok, A. T.C. Chan, C. M.L. Chan, V. Leong, S. H.T. Tsui, T. W.T. Leung, H. T.M. Wong, S. K.W. Ho, and P. J. Johnson
Quantification and Utility of Monosialylated {alpha}-Fetoprotein in the Diagnosis of Hepatocellular Carcinoma with Nondiagnostic Serum Total {alpha}-Fetoprotein
Clin. Chem., July 1, 2002; 48(7): 1021 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
S. Aschkenazi, S. Straszewski, K. M.A. Verwer, H. Foellmer, T. Rutherford, and G. Mor
Differential Regulation and Function of the Fas/Fas Ligand System in Human Trophoblast Cells
Biol Reprod, June 1, 2002; 66(6): 1853 - 1861.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. A. Butler, S. A. Khanlian, and L. A. Cole
Detection of Early Pregnancy Forms of Human Chorionic Gonadotropin by Home Pregnancy Test Devices
Clin. Chem., December 1, 2001; 47(12): 2131 - 2136.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. Yamamoto, M. Azuma, N. Hoshi, T. Kishida, S. Satomura, and S. Fujimoto
Lens culinaris agglutinin-reactive {alpha}-fetoprotein, an alternative variant to {alpha}-fetoprotein in prenatal screening for Down's syndrome
Hum. Reprod., November 1, 2001; 16(11): 2438 - 2444.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
L. A. Cole, S. Shahabi, S. A. Butler, H. Mitchell, E. S. Newlands, H. R. Behrman, and H. L. Verrill
Utility of Commonly Used Commercial Human Chorionic Gonadotropin Immunoassays in the Diagnosis and Management of Trophoblastic Diseases
Clin. Chem., February 1, 2001; 47(2): 308 - 315.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.